Morfina taldea - Euskara

Bibliografia
Meunier JC, Mollereau C. Toll L. Isolation and structure of the endogenous agonist of opioid
receptor-like ORL-1 receptor. Nature. 377: 532-535. 1995.
Mocchetti I, Costa E. Down regulation of hypothalamic proopiomelanocortin system during
morphine tolerance. Clin Neuropharmacol. 4: 125-127. 1986.
Mocchetti I, Ritter A, Costa E. Down-regulation of proopiomelanocortin synthesis and betaendorphin
utilization in hypothalamus of morphine-tolerant rats. J Mol Neurosci. 1: 33-38. 1989.
Mogenson GJ, Jones DL, Jim CY. From motivation to action: functional interface between the
limbic system and the motor system. Prog. Psychobiol. 14: 607-697. 1980.
Morain P, Lastage P, De Nanteuil G, Jochemsen R, Robin JL, Guez D, Boyer PA. S
17092: a prolyl endopeptidase inhibitor as potential therapeutic drug for memory imparment.
Preclinical and clinical studies. CNC Drug Rev. 8: 31-52. 2002.
Mosnaim AD, Puente J, Saavedra R, Diamond S, Wolf ME. In vitro human plasma
leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenotiazine
molecule in their chemical structure. Pharmacology. 67: 6-13. 2003.
Murphy NP, Ly HT, Maidment NT. Intracerebroventricular orphanin FQ/nociceptin
supresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 75: 1-4.
1996.
Naghettini AV, Nogueira pC, Juliano M, Bueno AA, Casarini DE, de Abreu
Carvalhaes JT. Tubular urinary enzymes in acute post-infectous glomerulonephritis. Pediatr.
Nephrol. 16: 719-722. 2001.
Nakanishi N, Inoue A, Kita T. Nucleotide sequence of clones cDNA for bovine corticotropinbeta-lipotropin
precursor. Nature 278. 1979.
Nestler EJ. Molecular mechanisms of drug addiction. J. Neurosci. 12: 2439-2450. 1992.
259
Doktore-tesia